APA (7th ed.) Citation

Q, D., JJ, S., AJ, P., LJ, M., JK, D., A, S., . . . DM, B. (2026). Trends in the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists among ischemic stroke patients. Cardiovascular diabetology. Endocrinology reports, 12(1), . https://doi.org/10.1186/s40842-026-00280-w

Chicago Style (17th ed.) Citation

Q, Ding, et al. "Trends in the Use of Sodium-glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists Among Ischemic Stroke Patients." Cardiovascular Diabetology. Endocrinology Reports 12, no. 1 (2026). https://doi.org/10.1186/s40842-026-00280-w.

MLA (9th ed.) Citation

Q, Ding, et al. "Trends in the Use of Sodium-glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists Among Ischemic Stroke Patients." Cardiovascular Diabetology. Endocrinology Reports, vol. 12, no. 1, 2026, https://doi.org/10.1186/s40842-026-00280-w.